Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
24-hour intragastric pH profile with fixed famotidine + omeprazole combination
2006-006726-26Phase 2Completed
- Sponsor
- Orexo AB
- Start
- Jan 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of omeprazole + famotidine in gastroesophageal reflux disease (GERD), sponsored by Orexo AB. Started Jan 2007; status: completed.
02
Drugs
omeprazole + famotidine
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on 2006-006726-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-006726-26.